Trade Mark Journal No.2026/040 2 October 2026

UK00004447534 18 September 2026 (1,5,40,42)

Mark 1

Image for mark UK00004447534_1of2 CONSTRUCTIVEBIO

Mark 2

Image for mark UK00004447534_2of2
Class 1
Nucleic acid sequences; artificial nucleic acid sequences; amino acid sequences; artificial amino acid sequences; enzymes for industrial purposes; enzymes for scientific purposes; proteins for industrial purposes; bacterial preparations for industrial use; biomaterials; biopolymers; biomolecules; bioplastics; bioesters; synthetic bacteria; recoded bacterial genomes; synthetic eukaryotic cells; recoded eukaryotic genomes; reagents for research purposes; bacteriophage-resistant bacteria for biomanufacturing; polypeptides containing non-proteinogenic amino acids for industrial purposes; polypeptides containing non-proteinogenic amino acids for scientific purposes; polypeptides containing non-canonical amino acids for industrial purposes; polypeptides containing non-canonical amino acids for scientific purposes.
Class 5
Pharmaceuticals; biotechnological preparations for medical and veterinary use; biopharmaceuticals for medical and veterinary use; enzymes for medical purposes; enzymes for veterinary purposes; bacterial preparations for medical purposes; bacterial preparations for veterinary purposes; antibodies; antibodies for medical purposes; antibody-drug conjugates; proteins for medical purposes; nucleic acid sequences for medical and veterinary purposes; peptides for medical and veterinary purposes; polypeptides containing non-proteinogenic amino acids for medical and veterinary purposes; polypeptides containing non-canonical amino acids for medical and veterinary purposes.
Class 40
Custom manufacturing services for the production of unnatural and synthetic biomaterials.
Class 42
Scientific and research services; research relating to medicines; research relating to proteins and amino acid sequences for industrial and medical purposes; research and development in the pharmaceutical and biotechnology fields; research and development for the pharmaceutical industry; research and development in the field of biomaterials; design and development of nucleic acid sequences, amino acid sequences, enzymes, bacteria, proteins and biomaterials; DNA synthesis; protein synthesis; DNA sequencing technology research; bioplastics technology research; drug discovery services; biomanufacturing research and development services; bioinformatics services relating to design and development of nucleic acid sequences, amino acid sequences, enzymes, bacteria, proteins and biomaterials; research relating to genetic code expansion.

Constructive Biology Limited

Representative: Alexander Bajjon